-
New ATAI Life Sciences-DemeRx Joint Venture Seeks To Combat Opioid Use Disorder With Ibogaine
Monday, January 27, 2020 - 8:06am | 263In 2018, 2.1 million Americans met the diagnostic criteria for opioid use disorder (OUD), with 47,600 people dying from overdoses. Current treatment options for OUD are not only limited, but often carry risk of significant side effects and abuse potential. In response to this huge unmet...